1-2 of 2
Andrew Hsu
Close
Sort by
Journal Articles

Postibrutinib relapse outcomes for patients with marginal zone lymphoma

Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K. Moyo, Nishitha Reddy, Julia Sheets, David M. Weiner, Praveen Ramakrishnan Geethakumari, Malathi Kandarpa, Ximena Jordan Bruno, Colin Thomas, Michael C. Churnetski, Andrew Hsu, Luke Zurbriggen, Xiao-wei Cherie Tan, Kathryn Lindsey, Joseph Maakaron, Paolo F. Caimi, Pallawi Torka, Celeste Bello, Sabarish Ayyappan, Timothy S. Oh, Reem Karmali, Seo-Hyun Kim, Anna Kress, Shalin Kothari, Yazeed Sawalha, Beth Christian, Kevin A. David, Irl Brian Greenwell, Murali Janakiram, Vaishalee P. Kenkre, Adam J. Olszewski, Jonathon B. Cohen, Neil Palmisiano, Elvira Umyarova, Ryan A. Wilcox, Farrukh T. Awan, Juan Pablo Alderuccio, Stefan K. Barta, Natalie S. Grover, Nilanjan Ghosh, Nancy L. Bartlett, Alex F. Herrera, Geoffrey Shouse
Journal: Blood Advances
Blood Adv (2023) 7 (1): 88–91.
https://doi.org/10.1182/bloodadvances.2022008634
Published: 2023
Includes: Supplemental data
Journal Articles

Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma

Clinical Trials & Observations
Adam J. Olszewski, Anna D. Chorzalska, Max Petersen, Thomas A. Ollila, Adam Zayac, Habibe Kurt, Diana O. Treaba, John L. Reagan, Andrew Hsu, Pamela C. Egan, James Butera, Rabin Niroula, John Vatkevich, Jordan Robison, Ilyas Sahin, Allison P. Jacob, Chelsea D. Mullins, Patrycja M. Dubielecka
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5525–5535.
https://doi.org/10.1182/bloodadvances.2021004512
Published: 2021
Includes: Supplemental data